Professor of Otolaryngology, University Mich Medical School
Otolaryngology (ENT)
Dr. Carol R. Bradford, MD
|
|
Give Review
Doctor Carol R. Bradford, MD is an expert in the field of Otolaryngology (ENT). She graduated from University of Michigan Medical School. She received awards:"CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)", "Fellow (FAAO-HNS)" and "President". Carol Bradford is a published physician as well. She has 100 publications published. The latest was: Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
Publications
- Comparisons of Dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.
- Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.
- Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
- Tumor infiltrating lymphocytes and survival in patients with Head and neck squamous cell carcinoma.
- Incidental Masticator Space Lesion in a Teenager.
- A novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in six new Head and neck squamous cell carcinoma lines.
- Chemoprophylaxis for Venous Thromboembolism in Otolaryngology.
- Update on primary Head and neck mucosal melanoma.
- Matted Nodes Predict Distant Metastasis in Advanced Stage III/IV Oropharyngeal Squamous Cell Carcinoma.
- Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck Cancer: translation from preclinical investigations aiming to improve the ther...
- Is sentinel lymph node biopsy the standard of care for cutaneous Head and neck melanoma?
- UM-SCC-103: A Unique Tongue Cancer Cell Line That Recapitulates the Tumorigenic Stem Cell Population of the Primary Tumor.
- Epigenetic alterations in metastatic cutaneous carcinoma.
- NCCN Guidelines Implementation in the Multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan.
- Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association With Poor Prognosis.
- When is chemotherapy in Head and neck squamous cell carcinoma not indicated?
- Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal Cancer.
- Cancer stem cells: Mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma.
- Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and Dysphagia-related predictors.
- Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal Cancer.
- Biomarkers in advanced larynx Cancer: Triological society thesis.
- Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced Oral cavity carcinoma.
- Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal Cancer.
- Impact of perineural invasion in the pathologically N0 Neck in oral cavity squamous cell carcinoma.
- Human papillomavirus-related oropharyngeal Cancer: HPV and p16 status in the recurrent versus parent tumor.
- Comparison of ultrasound-guided core biopsy versus fine-needle aspiration biopsy in the evaluation of salivary gland lesions.
- High-Risk Human Papillomavirus Detection in Oropharyngeal, Nasopharyngeal, and Oral Cavity Cancers: Comparison of Multiple Methods.
- Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx Cancer.
- Patterns of nodal metastasis and prognosis in human papillomavirus positive oropharyngeal squamous cell carcinoma.
- Head & neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy.
- Implementation of a novel otolaryngology clinic for indigent patients.
- Predictors of Recurrence and Survival for Head and Neck Mucoepidermoid Carcinoma.
- Head and Neck Cancer Stem Cells: The Effect of HPV--An In Vitro and Mouse Study.
- Neck spasm after chemoradiotherapy for head and neck Cancer: Natural history and dosimetric correlates.
- Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV positive and HPV negative locally advanced squ...
- Clinicopathologic Features of Primary Merkel Cell Carcinoma: A Detailed Descriptive Analysis of a Large Contemporary Cohort.
- Head and neck squamous cell carcinoma in pregnant women.
- Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6.
- Comprehensive analysis of DNA methylation in Head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics.
- Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma.
- In vitro cytokine release profile: Predictive value for metastatic potential in Head and neck squamous cell carcinomas.
- Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.
- A novel approach to biomarker discovery in head and neck Cancer using an autoantibody signature.
- Osteocutaneous Free Tissue Transplantation for Mandibular Osteoradionecrosis.
- Effect of erlotinib on epidermal growth factor receptor and downstream signaling in Oral cavity squamous cell carcinoma.
- Preoperative topical antimicrobial decolonization in Head and neck surgery.
- Pretreatment dietary intake is associated with tumor suppressor DNA methylation in Head and neck squamous cell carcinomas.
- Lean management in academic surgery.
- Diagnostic modalities for distant metastasis in Head and neck squamous cell carcinoma: are we changing life expectancy?
- Stratifying the Risk of Venous Thromboembolism in Otolaryngology.
- Transoral robotic biopsy of the Tongue base: A novel paradigm in the evaluation of unknown primary tumors of the head and neck.
- UM-SCC-104: A New human papillomavirus-16-positive Cancer stem cell-containing head and neck squamous cell carcinoma cell line.
- Advances and applications of oral Cancer basic research.
- Sentinel lymph node biopsy is accurate and prognostic in Head and neck melanoma.
- The Role of Full-Thickness Scalp Resection for Management of Primary Scalp Melanoma.
- Higher Micronutrient Intake Is Associated With Human Papillomavirus-Positive Head and Neck Cancer: A Case-Only Analysis.
- Chemo-IMRT of Oropharyngeal Cancer Aiming to Reduce Dysphagia: Swallowing Organs Late Complication Probabilities and Dosimetric Correlates.
- Sensitization of head and neck Cancer to Cisplatin through the use of a novel curcumin analog.
- Sternocleidomastoid muscle flap in preventing Frey's syndrome after parotidectomy: A systematic review.
- Clinical and Pathologic Predictors of Recurrence and Survival in Spindle Cell Squamous Cell Carcinoma.
- Mucosal melanoma of the Head and neck: predictors of prognosis.
- Features predicting sentinel lymph node positivity in Merkel cell carcinoma.
- Proposal for a rational classification of Neck dissections.
- Head and neck Cancer stem cells: the side population.
- Copy number variations and clinical outcome in atypical spitz tumors.
- Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal Cancer.
- Metastatic potential of Cancer stem cells in head and neck squamous cell carcinoma.
- Single-marker identification of head and neck squamous cell carcinoma Cancer stem cells with aldehyde dehydrogenase.
- Ethics of Frey syndrome: ensuring that consent is truly informed.
- Chemotherapy alone for organ preservation in advanced laryngeal Cancer.
- Intensity-modulated chemoradiotherapy aiming to reduce Dysphagia in patients with oropharyngeal cancer: clinical and functional results.
- HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
- Genotyping of 73 UM-SCC Head and neck squamous cell carcinoma cell lines.
- Tobacco use in human papillomavirus-positive advanced oropharynx Cancer patients related to increased risk of distant metastases and tumor recurrence.
- High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.
- Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
- Neuroendocrine neoplasms of the larynx: an overview.
- Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
- Oropharyngoplasty with template-based reconstruction of oropharynx defects.
- The pattern of failure after reirradiation of recurrent squamous cell head and neck Cancer: implications for defining the targets.
- Chemoselection as a strategy for organ preservation in patients with T4 Laryngeal squamous cell carcinoma with cartilage invasion.
- Skin Cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure.
- Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.
- Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during indu...
- Primary versus secondary trAcheoesophageal puncture in salvage total laryngectomy following chemoradiation.
- The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.
- Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
- Rectangle tongue template for reconstruction of the hemigLossectomy defect.
- Improved outcomes in patients with head and neck Cancer using a standardized care protocol for postoperative alcohol withdrawal.
- EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal Cancer.
- Chemoselection as a strategy for organ preservation in advanced oropharynx Cancer: response and survival positively associated with HPV16 copy number.
- Lateral oromandibular defect: when is it appropriate to use a bridging reconstruction plate combined with a soft tissue revascularized flap?
- Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon Cancer.
- Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
- Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol.
- Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal Cancer.
- Merkel cell carcinoma: critical review with guidelines for multidisciplinary management.
- Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck.
- Prevention of wound complications following salvage laryngectomy using free vascularized tissue.
Schools
Univ Of Mi Med Sch
St Joseph Hospital
University Of Mi
Procedures Preformed
- Continuous Positive Airway Pressure (CPAP)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ear Tube Placement
- Excision of Parotid, Sublingual, or Submandibular Gland
- View All
Conditions Treated
- Acoustic Neuroma
- Acute Laryngitis
- Acute Tonsillitis
- Allergic Rhinitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FAAO-HNS)
- President
Education
-
University of Michigan Hospitals and Health Centers -
St Joseph Mercy Livingston Hospital -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1710074588 | |
| NPPES Provider LastName | BRADFORD | |
| NPPES Provider FirstName | CAROL | |
| NPPES Provider ZIPCode | 481095312 | |
| NPPES Provider State | MI | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 169.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 15.38 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710074588 |
| Last Name Of The Provider | BRADFORD |
| First Name Of The Provider | CAROL |
| View All |
Similar Doctors
|
|
Dr. Andrew J. Rosko, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas B. Chepeha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shan R. Baker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc C. Thorne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Moyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles F. Koopmann Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman D. Hogikyan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew E. Spector, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin L. McKean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse T. Ryan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Brown, MD |
|
|
Dr. Sarah J. Burgin, MD |
|
Dr. Sarah J. Novis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xue Zhao, MD |
|
|
Dr. Susannah E. Hills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Zopf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer V. Brinkmeier, MD |